Clinical Trial Update: Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Paeoniflorin in combination with hepatoprotective drugs versus hepatoprotective drugs alone for autoimmune hepatitis has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis

Drugs mentioned

• Hepatoprotective drugs (unspecified)
• Paeoniflorin (paeoniflorin)

Snippet

Sponsor: Xiaoli Fan | Conditions: Hepatitis, Autoimmune | Phase 3 | Status: WITHDRAWN